全文获取类型
收费全文 | 965篇 |
免费 | 42篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 21篇 |
妇产科学 | 18篇 |
基础医学 | 157篇 |
口腔科学 | 76篇 |
临床医学 | 77篇 |
内科学 | 254篇 |
皮肤病学 | 10篇 |
神经病学 | 99篇 |
特种医学 | 71篇 |
外科学 | 87篇 |
综合类 | 14篇 |
预防医学 | 37篇 |
眼科学 | 3篇 |
药学 | 62篇 |
中国医学 | 3篇 |
肿瘤学 | 27篇 |
出版年
2022年 | 5篇 |
2021年 | 11篇 |
2020年 | 21篇 |
2019年 | 18篇 |
2018年 | 17篇 |
2017年 | 15篇 |
2016年 | 13篇 |
2015年 | 24篇 |
2014年 | 37篇 |
2013年 | 35篇 |
2012年 | 50篇 |
2011年 | 47篇 |
2010年 | 24篇 |
2009年 | 25篇 |
2008年 | 39篇 |
2007年 | 50篇 |
2006年 | 39篇 |
2005年 | 18篇 |
2004年 | 28篇 |
2003年 | 33篇 |
2002年 | 22篇 |
2001年 | 14篇 |
2000年 | 23篇 |
1999年 | 17篇 |
1998年 | 28篇 |
1997年 | 23篇 |
1996年 | 20篇 |
1995年 | 19篇 |
1994年 | 9篇 |
1993年 | 14篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 18篇 |
1989年 | 19篇 |
1988年 | 24篇 |
1987年 | 19篇 |
1986年 | 21篇 |
1985年 | 24篇 |
1984年 | 15篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 6篇 |
1980年 | 10篇 |
1979年 | 16篇 |
1978年 | 4篇 |
1977年 | 10篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1974年 | 8篇 |
1973年 | 5篇 |
排序方式: 共有1021条查询结果,搜索用时 328 毫秒
1.
Hugo Maia Julio Casoy Tania Correia Luís Freitas Kleber Pimentel Célia Athayde Elsimar Coutinho 《Gynecological endocrinology》2006,22(10):547-551
OBJECTIVES: To determine whether aromatase expression in the eutopic endometrium and adenomyotic foci is affected by previous use of oral contraceptives containing gestodene, and to determine whether changes in cyclooxygenase-2 (COX-2) expression occur in adenomyosis during the menstrual cycle. PATIENT AND METHODS: This was a retrospective cohort study carried out in paraffin-embedded endometrial tissue obtained from patients with a histological diagnosis of adenomyosis obtained during the proliferative (n = 25) and luteal (n = 10) phases of the menstrual cycle and following the use of continuous oral contraception with gestodene/ethinyl estradiol (n = 7). COX-2 and aromatase expression were measured in both eutopic endometrium and adenomyotic foci using immunohistochemical methods. RESULTS: Aromatase expression was detected in 80% of the endometrial slices by immunohistochemistry. In positive cases, aromatase was mainly detected in the stromal cells of the eutopic endometrium, whereas in the adenomyotic foci this expression was negative in the majority of the cases. Oral contraceptives containing gestodene, on the other hand, were effective in suppressing aromatase expression in both eutopic and ectopic endometrium. COX-2 expression was detected by immunohistochemistry in the glandular epithelium of both eutopic endometrium and adenomyotic foci and there were no significant changes in its intensity throughout the menstrual cycle. CONCLUSION: Aromatase expression in the eutopic endometrium and adenomyotic foci is suppressed by oral contraceptives containing gestodene. Increased aromatase activity may be responsible for the persistent COX-2 expression during the luteal phase. 相似文献
2.
Experimental results in female rats with marginal magnesium deficiency a and clinical results in over 100 female tetanic patients suggest the deleterious influence of magnesium on oro-facial tissues. 相似文献
3.
4.
B J Rounsaville T R Kosten H D Kleber 《The American journal of drug and alcohol abuse》1987,13(3):213-229
This report examines long-term and short-term benefits of achieving abstinence from opioids in a sample of opioid addicts who were reevaluated 2.5 years following seeking treatment. Extensive assessment of drug use history and drug-associated problems had been obtained when the subjects applied for treatment. At follow-up evaluations, detailed information was obtained on intervening course of drug use, treatment, legal problems, psychological problems, social functioning, occupational functioning, and medical status. The results were as follows: (1) Achieving abstinence from illicit opioids was associated with concurrent improvement in other aspects of functioning including reduction of criminal activity, improved medical status, improved social functioning, and reduced abuse of other psychoactive substances. However, many of these improvements were reversed immediately if relapse to opioid use occurred. (2) Achieving abstinence was associated with being in drug treatment, especially treatment in a methadone maintenance program. (3) Achievement of abstinence was not successfully predicted by client characteristics measured at entrance into treatment. (4) Long-range benefits of abstinence were detectable in social functioning even for those who had relapsed at the time of follow-up reevaluation. 相似文献
5.
Hans D de Boer Jan van Egmond Jacques J Driessen Leo HD Booij 《Neuropsychiatric Disease and Treatment》2007,3(5):539-544
Steroidal neuromuscular blocking agents (NMBAs), such as rocuronium, are widely used in clinical anesthesia and emergency medicine to facilitate endotracheal intubation and artificial ventilation and to allow surgical access to body cavities. Reversal of neuromuscular blockade is important for the acceleration of patient recovery and prevention of postoperative residual neuromuscular blockade and reduces the incidence of severe morbidity and mortality associated with anesthesia management. Sugammadex is the first selective relaxant binding agent (SRBA) and has been designed to reverse the steroidal neuromuscular blocking drug rocuronium. Encapsulation of the rocuronium molecule by sugammadex results in a rapid decrease in free rocuronium in the plasma and subsequently at the nicotinic receptor at the motor endplate. After encapsulation, rocuronium is not available to bind to the nicotinic receptor in the neuromuscular junction. This promotes the liberation of acetylcholine receptors, and muscle activity reappears. This new concept of reversal of neuromuscular block induced by rocuronium (or vecuronium) led to impressive results in animal and phase 1 and 2 studies. Sugammadex is currently in phase 3 clinical studies and may be commercially available by 2008. 相似文献
6.
7.
In vitro and in vivo precipitation of iodinated contrast agents when ioxaglate and papaverine are given together has been reported. To verify these reports and to investigate other medications not previously tested, the authors analyzed mixtures of contrast agents and medications in vitro with a light spectrophotometer and observed them for visible precipitates for up to 120 minutes. Previously reported incompatibilities between ionic or low-osmolality contrast media and medications were verified, and several new incompatibilities were discovered. No incompatibilities were found when the drugs tested were mixed with the new nonionic contrast media. 相似文献
8.
9.
10.